Jim Cramer - Mad Money incyte INCY-Q BUY Sep 22, 2025

Projected 19% earnings growth in 2026, yet trades at under 12x PE 2026. Has a robust drug pipeline.

Jim Cramer - Mad Money

Unknown

Unlock Rating

$84.730

Stock price when the opinion was issued

biotechnology

It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

Get Signals Create your Watchlist

You might be interested:

DON'T BUY

The momentum has broken badly and has a high PE. But he entered this on a rebound that has momentum. Despite an upgrade today, he doesn't see a green light ahead.

Most Recent Experts

Brendan Caldwell

Caldwell Securities

Larry Berman CFA, CMT, CTA

ETF Capital Management Inc.

Stockchase Insights

5i Research